ArticleCureus2025
Challenges in the Diagnosis of Autoimmune Hepatitis in Patients With Chronic Viral Hepatitis C: A Case Series and Review of the Literature.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Autoimmune Hepatitis After Successful Treatment of Chronic Hepatitis C Virus Infection with Direct-Acting Antivirals: A Pediatric Case Report.Pathogens (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Circulating non-organ-specific autoantibodies are commonly found in patients with chronic hepatitis C (CHC). Following the therapy for CHC, circulating autoantibodies such as anti-nuclear antibody (ANA), anti-smooth muscle antibody (ASMA), and anti-liver kidney-muscle-1 (LKM-1) antibodies tend to disappear; however, a subset of patients may develop overt immune-mediated disorders, including autoimmune hypothyroidism and autoimmune hepatitis (AIH). Development of AIH following CHC has been documented in the literature. Sometimes two conditions co-exist. Viral clearance unmask the features of overt AIH in such a group of patients. However, diagnosing AIH in the background of CHC and circulating autoantibodies is challenging. Data regarding the clinical implications of circulating autoantibodies and the risk of development of AIH in patients with CHC is scarce. Here, we present three cases of AIH that were diagnosed following successful treatment of CHC. The literature review aims to focus on the prevalence of circulating ANA, ASMA, and anti-LKM-1 in patients with CHC and their clinical implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.